DIA Biosimilars 2013

Nuclea Biotechnologies

Nuclea Biotechnologies acquires Oncogene Science, extends Wilex cooperation

Monday, September 9, 2013 12:05 PM

Pittsfield, Mass.-based Nuclea Biotechnologies has acquired all shares of Cambridge, Mass.-based Wilex (Oncogene Science), a wholly owned U.S. subsidiary of Wilex.

More... »

Cenduit: Now with Patient Reminders

Nuclea, BMC sign research agreement

Friday, June 21, 2013 01:28 PM

Nuclea Biotechnologies signed an R&D agreement with Berkshire Medical Center (BMC) that could lead to more effective treatment for prostate and breast cancer. This partnership will advance R&D biomarkers, which are a vital component in the field of personalized medicine.

More... »

CRF Health – eCOA Forum

Nuclea teams with SUNY for nanochip development

Friday, June 21, 2013 01:20 PM

SUNY’s College of Nanoscale Science & Engineering (CNSE) and Pittsfield, Mass.-based Nuclea Biotechnologies have launched a $1 million research partnership to enable the development and commercialization of a high-throughput nanochip to accelerate the diagnosis and treatment of breast, colon, prostate and other cancers.

More... »

Wilex, Nuclea Biotechnologies form partnership

Wednesday, March 20, 2013 10:08 AM

Pittsfield, Mass-based biomarker pioneer Nuclea Biotechnologies has formed a new long-term partnership with biopharmaceutical company Wilex, which could lead to more effective treatment management for women with metastatic breast cancer. The partnership aims to advance R&D of biomarkers, a vital component in the growing field of personalized medicine. 

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs